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We show that the C-131 monoclonal antibody, directed agamst chicken AChE, recognizes active chicken AChE, but not the SDS-denatured or 
heat-inactivated protein. Previous results indicated that C-131 only binds to the active enzyme, and not to inactive molecules which also occur in 
the embryonic chicken brain. In contrast with C-131, other monoclonal antibodies obtamed in the same series, such as C-6 and C-54, also recognize 
denatured or inactive AChE. It is noteworthy that these antibodies all seem to react with a trypsin-sensitive peptide which is present in chicken 
but not in mammalian or Torpedo AChE. whereas the C-131 antibody binds trypsin-modified as well as intact molecules. These results show that 
C-131 is highly conformation-dependent, specific for active AChE. They confirm our previous conclusion that actrve and inactive molecules arise 
from drfferent folding processes. 
Acetylcholinesterase: Monoclonal antibody; Active conformation; Chicken 
1. INTRODUCTION 
Acetylcholinesterase (AChE, EC 3.1.1.7) plays a key 
role in cholinergic synapses, by rapidly hydrolyzing the 
extracellularly released nemotransmitter, acetylcholine. 
This enzyme is synthesized in the endoplasmic reticulum 
and is then exported towards the cellular surface, where 
its different molecular forms may be anchored in the 
plasma membrane (amphiphilic globular forms), at- 
tached to the basal lamina (asymmetric collagen-tailed 
forms) or secreted as soluble molecules (non am- 
phiphilic globular forms) [1,2]. AChE is first synthe- 
sized as an inactive precursor, and acquires its catalytic 
activity in the rough endoplasmic reticulum after a lag 
of about 30 min, as shown by various experiments, in 
cultures of murine neuroblastoma T28 cells [3] and of 
primary chick muscle cells [4]. Rotundo and colleagues 
have shown that, in cultures of chick myotubes, about 
80% of the synthesized AChE polypeptides do not be- 
come active, and are rapidly degraded in a non- 
lysosomal compartment [5]. We have recently reported 
that in chicken brain, in vivo, a significant proportion 
of AChE proteins (about 30%) is catalytically inactive, 
or possesses a much lower catalytic turnover than the 
normal active enzyme [6]. This protein, however, pos- 
sesses an active serine which may react with organo- 
2.3. Solubilisatron of AChE 
Correspondence address; J.-M. Chatel, Laboratoire de Neurobiologie, Brains of chickens were homogenized in a Potter glass-teflon ho- 
CNRS URA 295, Ecole Normale Superieure, 46 rue d’Ulm, 75005 mogenizer wtth 5 ~01s. of buffer containing 50 mM Tris-HCI pH 7.5: 
Parrs, France. IO mM MgCI, (buffer A), 1% Triton X-100, supplemented with l/20 
12 
phosphate inhibitors, and co-sediments with active 
monomers (G,) and dimers (G,). 
We presently describe a monoclonal antibody, C- 13 1, 
which was raised against chicken AChE and seems to 
recognize only the active enzyme, but not the inactive 
component or denatured AChE. In addition, whereas 
the epitopes recognized by other antibodies seem to be 
located in a trypsin-sensitive region of chicken AChE, 
the binding of C-l 3 1 is not affected by a limited trypsin 
digestion. 
2. MATERIALS AND METHODS 
2.1. Mutrnals 
Antiproteolytic agents (EDTA, benzamidine, bacitracin, aprotmin 
or Zymofren, pepstatin A, leupeptin), as well as trypsin and soybean 
trypsin Inhibitor were obtained from Sigma (St. LOUIS. MO, USA). 
2.2. AChE actwit) 
AChE activity was determined by the calorimetric method of Ell- 
man 171, using acetyltiocholine as a substrate, in the presence of di- 
thto-bts-dinitrobenzorc acid. One Ellman umt (U) is defined as the 
amount of enzyme producing an increase m absorbance of I absorb- 
ance unit per minute in 1 ml of assay medium (1 cm pathlength). and 
corresponds to the hydrolysis of about 75 nmol of substrate per min. 
In the case of chicken AChE. 1 fig corresponds to approximately 28 
Ellman units [S]. 
The purtficatron of AChE was described previously [9, IO]. Hybrid- 
omas and ascites fluids were prepared essentially as described by 
Grassi et al. (1988) [l I]. 
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of a stock solution of antiproteolytic agents (20 mM EDTA; 2 mM 
benzamidine; 2mg/ml bacitracin; 50 U/ml aprotinin or Zymofren; 100 
mg/ml pepstatin A; 100 mg/ml leupeptin). The homogenate was then 
centrifuged at 15.000 rpm for 30 min at 4°C. 
2.4. Sedimentation analyses of AChE molecular forms 
The tissue extract was centrifuged for 16 h in sucrose gradients 
(S-20% sucrose, w/v) in a Beckman SW41 rotor, at 4”C, 40,000 rev/ 
min. The gradients were prepared in buffer A supplemented with 1% 
Triton X-100 or 1 M NaCl [12,13]. Sedimentation coefficients were 
determined by comparison with B-galactosidase from E. coli (16 S), 
catalase from beef liver (11.3 S), alkaline phosphatase from calf intes- 
tine (6.1 S), which were included as internal standards in the gradients. 
2.5. SDS-PAGE and Western blots 
Samples were denatured and reduced, in the presence of 0.25 M 
dithiothreitol, before electrophoresis n 10% SDS-polyacrylamide gels. 
Proteins were transferred to nitrocellulose membranes by electroblot- 
ting (0.6 mA during 3 h). The membrane was pre-incubated in buffer 
A containing 5% non-fat milk powder, and incubated overnight with 
a 11500 dilution of ascites fluid, in the same solution. The membrane 
was then washed, and incubated with antimouse IgG antibodies cou- 
pled with peroxidase (Diagnostics Pasteur, France). Peroxidase activ- 
ity was revealed with a reaction medium containing 50 mg diamino- 
benzidine. 0.1% HzO,, 50 mM Tris-HCl. pH 7.4. 
2.6. Digestion by trypsrn 
The samples were treated for 30 min at 4°C with trypsm (0.3 mg/ml). 
The reaction was stopped by the addition of soybean trypsin Inhibitor 
(0.2 mg/ml) and the tubes were kept on ice. 
2.7. Immunoradiometric assay of AChE protein 
AChE-immunoreactive protein was quantified by a two-site im- 
munoradiometric assay, similar to that used previously by Brimijoin 
et al. [14] for rat AChE. The purified monoclonal antibodies C-6 or 
C-131 were adsorbed to the walls of plastic tubes (capture antibody), 
and the second “51-labelled antibody C-54 was used at saturating 
concentration (tracer antibody). The method will be described in 
greater detail elsewhere (Chatel et al., m preparation). 
3. RESULTS 
3.1. Western blotting of chicken AChE with monoclonal 
antibodies 
We obtained a series of monoclonal antibodies which 
were selected according to their capacity to bind chicken 
AChE activity [6]. Most of these antibodies also recog- 
nize denatured AChE, in Western blots, staining AChE 
subunits and some degradation fragments (Fig. 1B). 
One of these antibodies, C- 13 1, differed however from 
the others because it did not produce any labeling in 
Western blots, as shown in Fig. lA, suggesting that it 
only recognized the native form of AChE. 
3.2. The monoclonal antibody C-131 does not recognize 
heat-denatured AChE 
The binding of AChE to antibodies C-l 3 1 and C-6 
was monitored by a two-site immunoradiometric assay 
[6]. In this assay one monoclonal antibody (capture 
antibody), C-6 or C-131, was immobilized on plastic 
tubes, and the amount of AChE bound on the solid- 
phase was quantified with a second, ‘251-labeled anti- 
body (tracer antibody), C-54. We analyzed the binding 
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Fig. 1. Western blots, showing the staining of chicken AChE with 
monoclonal antibodies. A detergent extract from brains of 11-day 
chick embryos was subjected to SDS-PAGE, transferred onto a nylon 
membrane, and stained with the monoclonal antibody C-l 31 (A) and 
with a pool of anti-AChE monoclonal antibodies (B). Lanes 1, 2 and 
3 correspond to samples containing 0.01, 0.02 and 0.03 Ellman units 
of AChE, respectively. Even at the lowest concentration, catalytic 
subunits of 100 and 110 kDa, corresponding to cc and ,!I alleles [ 161 as 
well as degradation fragments are clearly visible in B, but no stain can 
be detected with C-131, in A. 
of chicken AChE, which had been submitted to heat 
denaturation at 54°C for various periods of time (Fig. 
2). We found that activity disappeared within 15 min. 
This thermal denaturation is accompanied by a tran- 
sient increase followed by a subsequent reduction of the 
immunoreactivity when the C-6/C-54* assay was used. 
These effects may result from a variation of the affinity 
of the enzyme for the immobilized or for the labeled 
antibody. We did not investigate this point further. The 
signal obtained with the fully denatured enzyme was, 
however, more than half of that obtained with the na- 
tive extract, in agreement with the fact that both C-6 
and C-54 antibodies recognize denatured AChE in 
Western blots. In contrast, the signal was totally abol- 
ished when C-l 3 1 was used as capture antibody, exactly 
in parallel with the loss of catalytic activity, demonstrat- 
ing that this antibody recognizes only the native form 
of the enzyme. 
3.3. Effect of trypsin digestion of chicken AChE on the 
binding of C-6 and C-131 
A mild trypsin digestion modifies the sedimentation 
coefficients of all molecular forms of chicken AChE, 
probably by removing a peptidic region which is not 
involved in their catalytic activity or in their quaternary 
organization [15]. We characterized the binding of C- 
13 1 and other antibodies to intact and trypsin-modified 
forms of AChE, by analysing the capacity of the anti- 
bodies to shift their sedimentation in sucrose gradients. 
This is illustrated for C-131 and C-6 in Fig. 3. All anti- 
bodies displace the sedimentation of intact AChE peaks 
towards the bottom of the gradient (data not shown). 
13 
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In contrast, trypsin-modified AChE was not affected 
by most of our monoclonal antibodies, except C-l 31 
which clearly shifted the digested G,, G, and G, forms 
(Fig. 3). 
4. DISCUSSION 
We showed that the monoclonal antibody C- 13 1 does 
not bind detergent-denatured or heat-inactivated 
chicken AChE, in contrast with other monoclonal anti- 
bodies obtained in the same fusion, such as C-6 and 
C-54. These antibodies do not inhibit AChE activity, 
showing that they do not interact with the active site of 
the enzyme. In agreement with this, we found that the 
binding of these monoclonal antibodies, including C- 
13 1, is not affected by reaction of the active serine with 
the organophosphorus inhibitor 0-ethyl-S’-diisopropyl- 
aminoethylmethyl-phosphonothiotate (data not shown). 
We have recently shown that the quantification of 
immunoreactive AChE protein with monoclonal anti- 
bodies C-6 and C-54 reveals that the specific activity 
(catalytic activity/immunoreactive protein) is higher for 
the G, form than for the GZ and G, forms, in embryonic 
chicken brain [6]. Because purified AChE forms present 
an identical catalytic turnover per active site [S], this 
observation demonstrated the existence of inactive 
AChE molecules, co-sedimenting with G? and G,. On 
the contrary, when we used C-131 instead of C-6 as 
immobilized antibody, with the same radio-labelled an- 
tibody C-54, the radioactivity profile obtained by assay- 
ing fractions from a sucrose gradient was superimposa- 
ble with the profile of catalytic activity, indicating that 
C- 13 1 retained only active molecules. In addition, the 
ratio between catalytic activity and radioactivity was 
identical with C-6 and C- 13 1, in the case of the G, form, 
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Fig. 2. Effect of thermal denaturation on the reactivity of AChE with 
monoclonal antibodies C-6 and C-131. A total extract ofchicken brain 
was submitted to thermal denaturation at 54°C for the indicated times 
(abscissae): (-o-) enzymatic activity, (-•-) two-site immunoradiometric 
assay using C-6 as capture antibody, (-A-) two-site immunoradiomet- 
ric assay using C-131 as capture antibody. All values are normalized 
at 100% at 0 time. C-54 was used as the second ‘*51-labelled tracer 
antibody. 
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Fig. 3. The trypsin-modified AChE forms are recognized by the mon- 
oclonal antibody C-131. but not by C-6. A brain extract (cf. Fig. 1) 
was incubated for 1 h at 30°C with 0.3 mg/ml trypsin, and analyzed 
by sedimentation in a sucrose gradient, with or without addition of 
antibodies C-131 or C-6 (11100). (O--O) Control: the trypsin-digested 
AChE forms sediment at 4 S (G,). 6 S (GJ and 10 S (G,) instead of 
5 S, 7 S and 11 S for the intact forms; (O--O) the sedimentation of these 
forms IS not affected by C-6, in contrast to intact forms; (A--A) they 
are shifted towards the bottom of the gradient, showing that they form 
complexes with C-131. Note that a small fraction of the G, form 
remained intact after trypsin digestton. forming a shoulder on the left 
side of the mam peak, and was shifted in the presence of C-6. 
The present results confirm that C-131 is sensitive to the 
conformation of active AChE, since it has no affinity 
for denatured protein. 
It is interesting that the epitopes recognized by the 
conformation-independent antibodies are associated 
with a trypsin-sensitive region of chicken AChE. The 
catalytic subunit of chicken AChE has a mass of IOO- 
110 kDa [ 161, instead of 70-80 kDa for other vertebrate 
such as Torpedo and mammals [l]. The additional mass 
resides in the polypeptide chains themselves, and ap- 
pears to be due to the presence of a peptidic domain of 
235 amino acids, containing many glycines and prolines 
(75 and 17, respectively), which is encoded by an inser- 
tion in the AChE gene, around position 338 (Torpedo 
numbering) (Y. Maulet and M. Ballivet, unpublished 
results). All forms of chicken AChE thus sediment 
faster than their mammalian counterparts. A mild tryp- 
tic digestion, however, probably removes the additional 
peptide, because it reduces the sedimentation coeffi- 
cients to the values observed in mammals, without mod- 
ifying either the catalytic activity, or the quaternary 
organisation of the molecules; collagen-tailed and am- 
phiphilic molecules retain their specific properties [ 151. 
The antibodies C-6 and C-54, as well as all other confor- 
mation-independent antibodies, do not bind these mod- 
ified AChE forms, whereas C-l 3 1 recognizes the intact 
and digested molecules equally well. 
It would be extremely interesting to localize the re- 
gion of the enzyme which binds C-l 31, since this might 
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give us some information on the difference between 
active and inactive molecules. Unfortunately this can- 
not be determined by classical epitope-mapping meth- 
ods since only the complete, correctly folded polypep- 
tide chain is likely to be recognized by this antibody. It 
is interesting that C- 13 1 does not recognize the closely 
related quail AChE (Chatel et al., in preparation). 
When both coding sequences are available, a possible 
strategy for identifying residues involved in C- 13 1 bind- 
ing might be to construct chimeric proteins in which 
segments of chicken AChE would replace the corre- 
sponding quail peptides, hopefully in an active confor- 
mation so that they may bind the antibody. 
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is highly conformation-dependent, and recognizes only 
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